A gender-based analysis of retinal microvascular alterations in patients with diabetes mellitus using OCT angiography.

To assess the difference in microvascular changes between males and females with diabetes mellitus (DM) without diabetic retinopathy (NoDR) and with mild-to-moderate non-proliferative diabetic retinopathy (NPDR) using Optical Coherence Tomography Angiography (OCT-A). Retrospective cross-sectional study. 267 DM patients, 133 females (49.81 %), 111 with NoDR (41.57 %) and 156 NPDR (58.43 %) were included. Foveal-centered 3 × 3 mm OCT-A images corresponding to the superficial (SCP), intermediate (ICP) and deep capillary plexus (DCP), and full retinal (RET) slab were used for analysis. For each slab, FAZ area, perimeter, and circularity index (CI) were determined, following manual delineation of the FAZ; perfusion (PD) and vessel density (VD), fractal dimension (FD), vessel length density (VLD), geometric perfusion deficits (GPD) were also computed. Flow voids (FV) were determined in the choriocapillaris plexus; and perfused capillary density (PCD) in the RET slab. Females showed larger FAZ CI in SCP and greater FAZ area and perimeter than males in NPDR group. Males had higher central macular thickness than females in NPDR group. All density metrics at the level of ICP and DCP were affected in the NPDR group with no gender differences. Of note, the same significant findings were found in type 1 DM patients, and not in type 2 DM patients. Our OCT-A findings suggest significant microvascular changes in females with NPDR compared to males, but no such differences in patients without DR. Therefore, gender-related vascular alterations might be present in early stages of DR with potential role.

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of competing interest Stela Vujosevic: Consultant to Abbvie, Apellis, Bayer, Novartis, Hoffman La Roche, Zeiss; Paolo Nucci: Thea, Hoya, Essilor Luxottica e Fondazione One-sight, Sifi, Bausch& Lomb, Alfa Intes, Alcon, Doc, Santen, Eyerising. Mariacristina Parravano reports personal fees from Abbvie, Novartis, Bayer, La-Roche, Zeiss outside the submitted work. Celeste Limoli, Gabriele Piccoli, Eliana Costanzo, Elisa Marenzi, Emanuele Torti, Daniela Giannini, Maria Sole Polito and Livio Luzi have nothing to disclose.